MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Time-Frequency analysis of Gait-EEG signals for freezing of gait in a PD patient

    J. Li, Y. Zhang (Beijing, China)

    Objective: We used Gait-EEG to simultaneously record the three-axis acceleration and EEG during a PD patient’s timed-up-and-go (TUG) task, aimed to accurate identify and detect the…
  • 2019 International Congress

    Effectiveness of exome sequencing in Parkinson’s disease of Chinese population

    YW. Zhao, HX. Pan, L. Jiang, Y. He, Q. Zeng, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: The aim of this study was to evaluate rare damaging variants in disease-causing gene of Parkinson’s disease (PD) and other movement disorders, and to…
  • 2019 International Congress

    Discriminative power of different olfactory domains in Parkinson’s disease

    YW. Zhao, RC. He, JX. Yang, Y. Zhang, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: The aim of this study was to evaluate which kind of olfactory domain was the best in discriminating PD patients from controls, and to…
  • 2019 International Congress

    Factors associated with dyskinesia in Parkinson’s disease in Mainland China

    X. Zhou, LF. Fang, XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: To identify the association between dyskinesia and related risk factors, the medication dosage range considered safe and treatment-related variables.To identify the association between dyskinesia…
  • 2019 International Congress

    The Chinese Parkinson’s disease Registry scheme

    XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Q. Xu, Y. Tian, LJ. Fang, ZQ. Wang, QY. Sun, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: This large prospective longitudinal cohort aims to identify nature history of a highly-presentative Chinese PD population and to discern clinical and genetic markers which…
  • 2019 International Congress

    Characteristics and correlative factors of autonomic dysfunction in Chinese Parkinson’s disease

    Z. Zhou, LP. Zhu, XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Y. Yang, LJ. Fang, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: To study the clinical features and correlative factors of AutD in Chinese PD. Background: Autonomic dysfunction (AutD), which is defined as dysfunction of the…
  • 2019 International Congress

    Clinical features of constipation in patients with Parkinson’s disease: a cross-sectional study in China

    LP. Zhu, XT. Zhou, Z. Zhou, LJ. Fang, XX. Zhou, YW. Zhao, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: This study was designed to explore the clinical features of constipation, and investigate the risk factors of constipation in Chinese PD patients. Background: Constipation…
  • 2019 International Congress

    Levodopa Induced dyskinesia in patients with Parkinson’s disease and polymorphisms gene DRD3 dopamine receptor

    I. Zhukova, N. Zhukova, E. Kolupaeva, S. Ivanova, M. Nikitina, O. Izhboldina, I. Mironova (Tomsk, Russian Federation)

    Objective: The aim of this study was to investigate the association between two DRD3 gene single-nucleotide polymorphisms (SNPs) and the development of LID in patients…
  • 2019 International Congress

    Ambroxol treatment of primary macrophages derived from patients with GBA-associated Parkinson’s disease

    A. Kopytova, M. Nikolaev, K. Senkevich, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

    Objective: The aim was to evaluate the effectiveness of the restoration of GCase activity in macrophages from GBA-PD patients using pharmacological chaperone ambroxol. Background: Mutations…
  • 2019 International Congress

    Relationship of cognitive processing speed with postural stability in non-demented Parkinson’s disease patients

    J. Andreo Jover, A. Arroyo Ferrer, P. López Serrano, J. Periañez, M. Rios-Lago, G. Lubrini, JP. Romero Muñoz (Madrid, Spain)

    Objective: To measure in PD patients with normal cognitive screening the clinical and instrumental measures of postural stability (PS) and analyze their relationship with cognitive…
  • « Previous Page
  • 1
  • …
  • 1307
  • 1308
  • 1309
  • 1310
  • 1311
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley